Literature DB >> 25189191

MDCT features of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumours.

S H Tirumani1, H Tirumani, J P Jagannathan, A B Shinagare, J L Hornick, S George, A J Wagner, N H Ramaiya.   

Abstract

OBJECTIVE: To describe the multidetector CT (MDCT) features and metastatic pattern of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumours (GISTs).
METHODS: In this institutional review board-approved, Health Insurance Portability and Accountability Act-compliant study, we retrospectively identified 34 patients (20 females; mean age, 34 years; range, 12-59 years) with histopathology-confirmed SDH-deficient GIST, who were seen at our institution from 1999 through 2012. MDCT of primary tumour in 8 patients and follow-up imaging in all 34 patients over median follow-up of 106 months [interquartile range (IQR), 52-175 months] were reviewed by two radiologists in consensus. Clinical information was extracted from electronic medical records.
RESULTS: Primary tumour in all 34 patients was located in the stomach. Mean tumour size (n = 8) was 9.6 cm (range, 8-14 cm). Primary tumours were lobulated, variable in growth pattern, hypo- (1/8) to isodense (7/8) and similar in enhancement to the skeletal muscle. Two were multifocal, four of eight had necrosis and one of eight had haemorrhage. Tumour rupture with haemoperitoneum and tumour-bowel fistula was noted in one patient each. During follow-up, 12/34 patients developed tumour in surgical bed, and 28/34 patients developed metastases. Most common sites of metastases were the liver (24/34), peritoneum (20/34) and lymph nodes (18/34). Carney triad and Carney-Stratakis syndrome were noted in 5/34 and 1/34 patients, respectively. At the time of writing, six patients had deceased at a median interval of 109 months (IQR, 54-126 months).
CONCLUSION: SDH-deficient GISTs occur in young patients, commonly arise in stomach, can be multifocal and may be associated with Carney triad or Carney-Stratakis syndrome. They frequently metastasize to lymph nodes in addition to the liver and peritoneum and are associated with indolent course despite metastatic spread. ADVANCES IN KNOWLEDGE: The presence of features unusual for conventional GIST on imaging should alert the radiologist for the possibility of SDH-deficient GIST, especially, because SDH-deficient GISTs are resistant to imatinib. Young age at diagnosis, prolonged survival, association with Carney triad and Carney-Stratakis syndrome and occurrence of concurrent renal cell carcinoma and thyroid malignancies necessitates long-term follow-up of patients with SDH-deficient GISTs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25189191      PMCID: PMC4207163          DOI: 10.1259/bjr.20140476

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  19 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Authors:  Katherine A Janeway; Su Young Kim; Maya Lodish; Vânia Nosé; Pierre Rustin; José Gaal; Patricia L M Dahia; Bernadette Liegl; Evan R Ball; Margarita Raygada; Angela H Lai; Lorna Kelly; Jason L Hornick; Maureen O'Sullivan; Ronald R de Krijger; Winand N M Dinjens; George D Demetri; Cristina R Antonescu; Jonathan A Fletcher; Lee Helman; Constantine A Stratakis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 3.  Resistance to treatment in gastrointestinal stromal tumours: what radiologists should know.

Authors:  S H Tirumani; J P Jagannathan; J L Hornick; N H Ramaiya
Journal:  Clin Radiol       Date:  2013-04-25       Impact factor: 2.350

4.  Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.

Authors:  T Aparicio; V Boige; J-C Sabourin; P Crenn; M Ducreux; A Le Cesne; S Bonvalot
Journal:  Eur J Surg Oncol       Date:  2004-12       Impact factor: 4.424

5.  Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.

Authors:  Anthony J Gill; Angela Chou; Ricardo Vilain; Adele Clarkson; Millie Lui; Richard Jin; Vivienne Tobias; Jaswinder Samra; David Goldstein; Celia Smith; Loretta Sioson; Nicole Parker; Ross C Smith; Mark Sywak; Stan B Sidhu; Jenny Ma Wyatt; Bruce G Robinson; Robert P Eckstein; Diana E Benn; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

6.  Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.

Authors:  Markku Miettinen; Zeng-Feng Wang; Maarit Sarlomo-Rikala; Czeslaw Osuch; Piotr Rutkowski; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2011-11       Impact factor: 6.394

7.  Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

Authors:  Ronald P Dematteo; Jason S Gold; Lisa Saran; Mithat Gönen; Kui Hin Liau; Robert G Maki; Samuel Singer; Peter Besmer; Murray F Brennan; Cristina R Antonescu
Journal:  Cancer       Date:  2008-02-01       Impact factor: 6.860

Review 8.  Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients < or = 40 years: an overview based on our case material and the literature.

Authors:  Abbas Agaimy; Peter H Wünsch
Journal:  Langenbecks Arch Surg       Date:  2008-12-23       Impact factor: 3.445

9.  Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.

Authors:  Katherine A Janeway; Bernadette Liegl; Amy Harlow; Claudia Le; Antonio Perez-Atayde; Harry Kozakewich; Christopher L Corless; Michael C Heinrich; Jonathan A Fletcher
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

Review 10.  Gastrointestinal stromal tumors (GIST): lesser known facts.

Authors:  Kevin N O'Regan; Atul B Shinagare; Sachin S Saboo; Nikhil H Ramaiya; Jyothi P Jagannathan; Sree Harsha Tirumani
Journal:  Clin Imaging       Date:  2013-07-09       Impact factor: 1.605

View more
  5 in total

Review 1.  Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 1-Common Sarcomas: From the Radiologic Pathology Archives.

Authors:  Angela D Levy; Maria A Manning; Waddah B Al-Refaie; Markku M Miettinen
Journal:  Radiographics       Date:  2017 Mar-Apr       Impact factor: 5.333

Review 2.  Update on Gastrointestinal Stromal Tumors for Radiologists.

Authors:  Sree Harsha Tirumani; Akshay D Baheti; Harika Tirumani; Ailbhe O'Neill; Jyothi P Jagannathan
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

3.  Carney-Stratakis syndrome: A dyad of familial paraganglioma and gastrointestinal stromal tumor.

Authors:  Hannah S Recht; Elliot K Fishman
Journal:  Radiol Case Rep       Date:  2020-09-02

4.  Hepatic GIST metastases: an illustrative case series.

Authors:  Cathryn Hui; Reuben Sum
Journal:  BJR Case Rep       Date:  2022-01-10

Review 5.  Cancer genome landscape: a radiologist's guide to cancer genome medicine with imaging correlates.

Authors:  Francesco Alessandrino; Daniel A Smith; Sree Harsha Tirumani; Nikhil H Ramaiya
Journal:  Insights Imaging       Date:  2019-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.